Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment

BACKGROUND: Optimal dosing of oral tyrosine kinase inhibitor therapy is critical to treatment success and survival of patients with chronic myeloid leukemia (CML). Drug intolerance secondary to toxicities and nonadherence are significant factors in treatment failure. OBJECTIVE: The objective of this...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:JMIR Mhealth Uhealth
Päätekijät: Pereira-Salgado, Amanda, Westwood, Jennifer A, Russell, Lahiru, Ugalde, Anna, Ortlepp, Bronwen, Seymour, John F, Butow, Phyllis, Cavedon, Lawrence, Ong, Kevin, Aranda, Sanchia, Breen, Sibilah, Kirsa, Suzanne, Dunlevie, Andrew, Schofield, Penelope
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: JMIR Publications 2017
Aiheet:
Original Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5738545/
https://ncbi.nlm.nih.gov/pubmed/29212628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/mhealth.8349
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia